b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Process" Owner="NLM">\n        <PMID Version="1">31668650</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>06</Month>\n            <Day>12</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Print">0929-6646</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>119</Volume>\n                    <Issue>2</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Feb</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of the Formosan Medical Association = Taiwan yi zhi</Title>\n                <ISOAbbreviation>J. Formos. Med. Assoc.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Anti-PD-1 immunotherapy in advanced esophageal squamous cell carcinoma: A long-awaited breakthrough finally arrives.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>565-568</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0929-6646(19)30894-0</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jfma.2019.10.010</ELocationID>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Kuo</LastName>\n                    <ForeName>Hung-Yang</ForeName>\n                    <Initials>HY</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Guo</LastName>\n                    <ForeName>Jhe-Cyuan</ForeName>\n                    <Initials>JC</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Hsu</LastName>\n                    <ForeName>Chih-Hung</ForeName>\n                    <Initials>CH</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: chihhunghsu@ntu.edu.tw.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>23</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Singapore</Country>\n            <MedlineTA>J Formos Med Assoc</MedlineTA>\n            <NlmUniqueID>9214933</NlmUniqueID>\n            <ISSNLinking>0929-6646</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <CoiStatement>Declaration of Competing Interest C\xe2\x80\x93H Hsu reports receiving honoraria from BMS, MSD, ONO Pharmaceutical Company, and Roche; serving in a consulting role for BMS, MSD, ONO Pharmaceutical Company, and Roche; and receiving research funding from MSD. H.Y. Kuo and J.C. Guo report no conflicts of interest.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>05</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>10</Month>\n                <Day>14</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>2</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>2</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31668650</ArticleId>\n            <ArticleId IdType="pii">S0929-6646(19)30894-0</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.jfma.2019.10.010</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'